HAIQU (Hospital AIr QUality)
NCT07670117 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 850
Last updated 2026-06-29
Summary
The purpose of this research is to assess whether integration of an aerosol biosensor and air quality risk assessment software that integrates into a building management system will improve indoor air quality metrics in hospital environments and reduces risk factors associated with respiratory disease transmission.
Conditions
- Acute Respiratory Tract Infection
Interventions
- DIAGNOSTIC_TEST
-
Self-swab test
Participants will self-report when they are experiencing respiratory symptoms and will be asked for a self-swab to be used for data analysis.
Sponsors & Collaborators
-
Advanced Research Projects Agency for Health
collaborator UNKNOWN -
Roche Pharma AG
collaborator INDUSTRY - lead OTHER
Principal Investigators
-
Chung Wi, M.D. · Mayo Clinic
-
Connie Chang, Ph.D. · Mayo Clinic
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-10-01
- Primary Completion
- 2029-09-30
- Completion
- 2029-09-30
Countries
- United States
Study Locations
More Related Trials
-
Holistic Approach Supporting the Uptake of Innovative Diagnostic Technologies for Respiratory Infections
NCT07651865 ·Status: RECRUITING
-
Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections
NCT06775106 ·Status: RECRUITING
-
Point of Care Respiratory Pathogen Testing for Antibiotic Stewardship in Primary Care
NCT06765135 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Artificial Intelligence for Respiratory Infections SEverity Prediction
NCT07047768 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Study of Transcriptome-based Diagnostic Biomarker for Acute Febrile Illness
NCT06552975 ·Status: RECRUITING
-
Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies
NCT04772170 ·Status: RECRUITING
-
Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection System
NCT04311398 ·Status: UNKNOWN
-
Viral Testing and Biomarkers to Reduce Antibiotic Use for Respiratory Infections
NCT01907659 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Respiratory Specimens for Bacterial and Viral Pathogens by Real-Time PCR
NCT00275691 ·Status: COMPLETED
-
Real-Time Mass Spectrometry Breath Analysis for the Investigation of Respiratory Tract Infections
NCT07685275 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
FebriDx® Method Comparison Study Protocol
NCT06746259 ·Status: COMPLETED
-
Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B
NCT01431768 ·Status: COMPLETED ·Phase: NA
-
Volatile Organic Compounds Analysis by GC-MS for Diagnostic of Hospitalised Patients With Respiratory Infections Using Exhaled Breath
NCT07352462 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Noninvasive Multimodal Biosensing Device for Screening and Monitoring Response to Treatment of Infectious Respiratory Diseases
NCT05035420 ·Status: COMPLETED ·Phase: NA
-
Role of Multiplex PCR in CAP
NCT06097117 ·Status: NOT_YET_RECRUITING
-
Detecting Respiratory Viruses in Upper and Lower Respiratory Tract Samples
NCT01597089 ·Status: TERMINATED
-
Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical Validation
NCT05364268 ·Status: COMPLETED
-
mNGS for Detection of Pathogens for Pulmonary Infection
NCT03798925 ·Status: UNKNOWN
-
Q-POC SARS-CoV-2 Assay COVID-19 Clinical Evaluation
NCT05614011 ·Status: COMPLETED ·Phase: NA
-
Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial)
NCT04397692 ·Status: TERMINATED ·Phase: NA
-
Collection and Testing of Respiratory Samples
NCT01302418 ·Status: COMPLETED
-
Rapid Detection of Pseudomonas Aeruginosa in Bronchoalveolar Lavage Fluid Using Label-free Single-particle Imaging Technology and Assessment of Post-treatment Efficacy in Patients With Pseudomonas Aeruginosa Infection
NCT06986512 ·Status: NOT_YET_RECRUITING
-
Nitazoxanide Versus Placebo for the Treatment of Hospitalized Subjects With Severe Acute Respiratory Illness
NCT02057757 ·Status: COMPLETED ·Phase: PHASE2
-
Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy
NCT00001477 ·Status: COMPLETED
-
Promotion and Application of a New Three-level Etiological Diagnosis Strategy for Fever Clinics in Respiratory Infectious Diseases
NCT05965128 ·Status: RECRUITING